

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.16225271 |
| 2 | central nervous system myelination (GO:0022010) | 5.16225271 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.91901490 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.47881165 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.47881165 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.47881165 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.47881165 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.47881165 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.47881165 |
| 10 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.31177326 |
| 11 | respiratory burst (GO:0045730) | 4.08423315 |
| 12 | desmosome organization (GO:0002934) | 4.06296528 |
| 13 | endosome to melanosome transport (GO:0035646) | 4.03354097 |
| 14 | endosome to pigment granule transport (GO:0043485) | 4.03354097 |
| 15 | cellular response to ATP (GO:0071318) | 3.99510455 |
| 16 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.82964785 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.79157955 |
| 18 | myelin maintenance (GO:0043217) | 3.70541012 |
| 19 | protein localization to endosome (GO:0036010) | 3.63061049 |
| 20 | amine catabolic process (GO:0009310) | 3.46901535 |
| 21 | cellular biogenic amine catabolic process (GO:0042402) | 3.46901535 |
| 22 | mannosylation (GO:0097502) | 3.46456198 |
| 23 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.44642173 |
| 24 | ensheathment of neurons (GO:0007272) | 3.43082768 |
| 25 | axon ensheathment (GO:0008366) | 3.43082768 |
| 26 | glycosylceramide metabolic process (GO:0006677) | 3.41007678 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.40689345 |
| 28 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.38830983 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35464685 |
| 30 | regulation of hippo signaling (GO:0035330) | 3.33707174 |
| 31 | amyloid precursor protein catabolic process (GO:0042987) | 3.32424326 |
| 32 | kynurenine metabolic process (GO:0070189) | 3.29956459 |
| 33 | amyloid precursor protein metabolic process (GO:0042982) | 3.29302901 |
| 34 | myelination (GO:0042552) | 3.27579828 |
| 35 | response to lipoprotein particle (GO:0055094) | 3.25049216 |
| 36 | phagosome maturation (GO:0090382) | 3.16952339 |
| 37 | granulocyte activation (GO:0036230) | 3.16893650 |
| 38 | negative regulation of platelet activation (GO:0010544) | 3.16467908 |
| 39 | tryptophan catabolic process (GO:0006569) | 3.08585358 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 3.08585358 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 3.08585358 |
| 42 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.08158465 |
| 43 | virion attachment to host cell (GO:0019062) | 3.07614784 |
| 44 | adhesion of symbiont to host cell (GO:0044650) | 3.07614784 |
| 45 | angiogenesis involved in wound healing (GO:0060055) | 3.05874276 |
| 46 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.04856487 |
| 47 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.04553010 |
| 48 | negative regulation of focal adhesion assembly (GO:0051895) | 3.03938741 |
| 49 | negative regulation of cell junction assembly (GO:1901889) | 3.03938741 |
| 50 | negative regulation of adherens junction organization (GO:1903392) | 3.03938741 |
| 51 | creatine metabolic process (GO:0006600) | 3.02541197 |
| 52 | neutrophil activation (GO:0042119) | 3.01028332 |
| 53 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.99858520 |
| 54 | negative regulation of protein localization to cell surface (GO:2000009) | 2.99156437 |
| 55 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.97904778 |
| 56 | NAD biosynthetic process (GO:0009435) | 2.92625693 |
| 57 | low-density lipoprotein particle clearance (GO:0034383) | 2.92313970 |
| 58 | cardiac right ventricle morphogenesis (GO:0003215) | 2.89730697 |
| 59 | platelet dense granule organization (GO:0060155) | 2.89404485 |
| 60 | fatty acid elongation (GO:0030497) | 2.89311898 |
| 61 | GDP-mannose metabolic process (GO:0019673) | 2.88129460 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 2.86270044 |
| 63 | L-amino acid import (GO:0043092) | 2.85886169 |
| 64 | membrane raft organization (GO:0031579) | 2.84814196 |
| 65 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.84394224 |
| 66 | cortical actin cytoskeleton organization (GO:0030866) | 2.83880058 |
| 67 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.83124522 |
| 68 | cortical cytoskeleton organization (GO:0030865) | 2.82237856 |
| 69 | hepatocyte apoptotic process (GO:0097284) | 2.82041777 |
| 70 | regulation of water loss via skin (GO:0033561) | 2.80583260 |
| 71 | positive regulation of leukocyte degranulation (GO:0043302) | 2.76974150 |
| 72 | establishment of skin barrier (GO:0061436) | 2.75854228 |
| 73 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.75359336 |
| 74 | positive regulation of prostaglandin secretion (GO:0032308) | 2.74718508 |
| 75 | nitric oxide biosynthetic process (GO:0006809) | 2.74664178 |
| 76 | intestinal epithelial cell development (GO:0060576) | 2.73007792 |
| 77 | response to thyroid hormone (GO:0097066) | 2.72848227 |
| 78 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.70536445 |
| 79 | keratinocyte development (GO:0003334) | 2.69478053 |
| 80 | glycerophospholipid catabolic process (GO:0046475) | 2.68924262 |
| 81 | regulation of metalloenzyme activity (GO:0048552) | 2.67819558 |
| 82 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.67592748 |
| 83 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.67314013 |
| 84 | sphingoid metabolic process (GO:0046519) | 2.66022386 |
| 85 | response to peptidoglycan (GO:0032494) | 2.65904667 |
| 86 | nucleotide transmembrane transport (GO:1901679) | 2.65114896 |
| 87 | multicellular organism reproduction (GO:0032504) | 2.64651209 |
| 88 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.64165312 |
| 89 | aromatic amino acid family catabolic process (GO:0009074) | 2.64125373 |
| 90 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.62587505 |
| 91 | tyrosine metabolic process (GO:0006570) | 2.62133841 |
| 92 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.61851230 |
| 93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.61573227 |
| 94 | response to host immune response (GO:0052572) | 2.61573227 |
| 95 | regulation of integrin activation (GO:0033623) | 2.61546466 |
| 96 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.60798946 |
| 97 | vagina development (GO:0060068) | 2.60329218 |
| 98 | endothelium development (GO:0003158) | 2.59559323 |
| 99 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.59164753 |
| 100 | myeloid cell homeostasis (GO:0002262) | 2.58554823 |
| 101 | aromatic amino acid family metabolic process (GO:0009072) | 2.57879160 |
| 102 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.57593796 |
| 103 | response to nerve growth factor (GO:1990089) | 2.56412266 |
| 104 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.56412266 |
| 105 | leukocyte aggregation (GO:0070486) | 2.55660802 |
| 106 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.55385005 |
| 107 | L-phenylalanine metabolic process (GO:0006558) | 2.55385005 |
| 108 | plasma membrane fusion (GO:0045026) | 2.53477801 |
| 109 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.52362840 |
| 110 | regulation of establishment of cell polarity (GO:2000114) | 2.50568747 |
| 111 | immunoglobulin mediated immune response (GO:0016064) | 2.49280294 |
| 112 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.48303115 |
| 113 | regulation of mononuclear cell migration (GO:0071675) | 2.48245744 |
| 114 | superoxide anion generation (GO:0042554) | 2.48022576 |
| 115 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.47884132 |
| 116 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.47293077 |
| 117 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.46548021 |
| 118 | positive regulation of interferon-alpha production (GO:0032727) | 2.46169241 |
| 119 | regulation of early endosome to late endosome transport (GO:2000641) | 2.46057814 |
| 120 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.45711982 |
| 121 | indolalkylamine metabolic process (GO:0006586) | 2.45222639 |
| 122 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.44970916 |
| 123 | response to methylmercury (GO:0051597) | 2.43835382 |
| 124 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.43815152 |
| 125 | negative regulation of cell killing (GO:0031342) | 2.43815152 |
| 126 | growth hormone receptor signaling pathway (GO:0060396) | 2.43121741 |
| 127 | regulation of glomerulus development (GO:0090192) | 2.43059471 |
| 128 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.42787052 |
| 129 | response to laminar fluid shear stress (GO:0034616) | 2.42760355 |
| 130 | autophagic vacuole fusion (GO:0000046) | 2.42438582 |
| 131 | pseudouridine synthesis (GO:0001522) | 2.41824275 |
| 132 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.41730303 |
| 133 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.41612198 |
| 134 | positive regulation of mast cell activation (GO:0033005) | 2.40571271 |
| 135 | adenosine receptor signaling pathway (GO:0001973) | 2.40458072 |
| 136 | purinergic receptor signaling pathway (GO:0035587) | 2.40457015 |
| 137 | pH reduction (GO:0045851) | 2.40011789 |
| 138 | adhesion of symbiont to host (GO:0044406) | 2.39761346 |
| 139 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.39641752 |
| 140 | response to muramyl dipeptide (GO:0032495) | 2.39394389 |
| 141 | positive regulation of fatty acid oxidation (GO:0046321) | 2.38729414 |
| 142 | microglial cell activation (GO:0001774) | 2.38492123 |
| 143 | mast cell activation (GO:0045576) | 2.38248451 |
| 144 | Rap protein signal transduction (GO:0032486) | 2.37350009 |
| 145 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37168342 |
| 146 | regulation of cholesterol storage (GO:0010885) | 2.37120556 |
| 147 | diol metabolic process (GO:0034311) | 2.36945138 |
| 148 | protein complex biogenesis (GO:0070271) | 2.36752931 |
| 149 | regulation of interferon-alpha production (GO:0032647) | 2.36321136 |
| 150 | tryptophan metabolic process (GO:0006568) | 2.35850066 |
| 151 | intracellular pH reduction (GO:0051452) | 2.35037292 |
| 152 | negative regulation of kidney development (GO:0090185) | 2.33338877 |
| 153 | negative regulation of macroautophagy (GO:0016242) | 2.32948773 |
| 154 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.31847856 |
| 155 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.31747048 |
| 156 | positive regulation of hormone metabolic process (GO:0032352) | 2.31458193 |
| 157 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.31244241 |
| 158 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.31244241 |
| 159 | negative regulation of macrophage differentiation (GO:0045650) | 2.31156876 |
| 160 | positive regulation of odontogenesis (GO:0042482) | 2.30933407 |
| 161 | positive regulation of p38MAPK cascade (GO:1900745) | 2.30912428 |
| 162 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.30551270 |
| 163 | hemidesmosome assembly (GO:0031581) | 2.30355397 |
| 164 | glutathione biosynthetic process (GO:0006750) | 2.30097721 |
| 165 | amino acid import (GO:0043090) | 2.29655147 |
| 166 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.29558376 |
| 167 | phagocytosis, recognition (GO:0006910) | 2.29487611 |
| 168 | semaphorin-plexin signaling pathway (GO:0071526) | 2.29142923 |
| 169 | basic amino acid transport (GO:0015802) | 2.28379803 |
| 170 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.27979281 |
| 171 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.27824764 |
| 172 | behavioral response to nicotine (GO:0035095) | 2.27633109 |
| 173 | macrophage activation (GO:0042116) | 2.27234183 |
| 174 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.27163578 |
| 175 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.27163578 |
| 176 | nodal signaling pathway (GO:0038092) | 2.26991615 |
| 177 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.26524697 |
| 178 | NADH dehydrogenase complex assembly (GO:0010257) | 2.26524697 |
| 179 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.26524697 |
| 180 | female genitalia development (GO:0030540) | 2.24952577 |
| 181 | import into cell (GO:0098657) | 2.24673905 |
| 182 | high-density lipoprotein particle remodeling (GO:0034375) | 2.24525424 |
| 183 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.24411689 |
| 184 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.23577325 |
| 185 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.22924256 |
| 186 | negative regulation of cell cycle arrest (GO:0071157) | 2.22923418 |
| 187 | heterotypic cell-cell adhesion (GO:0034113) | 2.21907658 |
| 188 | rRNA modification (GO:0000154) | 2.21859649 |
| 189 | cellular extravasation (GO:0045123) | 2.21506993 |
| 190 | response to host defenses (GO:0052200) | 2.21093415 |
| 191 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.21093415 |
| 192 | response to host (GO:0075136) | 2.21093415 |
| 193 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.20409252 |
| 194 | activated T cell proliferation (GO:0050798) | 2.19611261 |
| 195 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.19298483 |
| 196 | positive regulation of macrophage cytokine production (GO:0060907) | 2.19159526 |
| 197 | neutrophil migration (GO:1990266) | 2.18931516 |
| 198 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.17382029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.35295389 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.26250495 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.17727718 |
| 4 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 3.78047000 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.24819884 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19680223 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17893054 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.05493742 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84063429 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75409444 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35365334 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.33045775 |
| 13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.25992500 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.25130930 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15986941 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.15878751 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11207409 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11035301 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.05335431 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02621138 |
| 21 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.93625438 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.93130535 |
| 23 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.90028176 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79380143 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77116338 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73291893 |
| 27 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.72195054 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71765224 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66798195 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65872994 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65066432 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63001828 |
| 33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.61037066 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59668103 |
| 35 | ATF3_27146783_Chip-Seq_COLON_Human | 1.57416772 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54235978 |
| 37 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.54086129 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53889109 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.53773657 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51949823 |
| 41 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.51874352 |
| 42 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47725902 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47179410 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46869089 |
| 45 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45753642 |
| 46 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45753642 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45305850 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45247616 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44989095 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43674945 |
| 51 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42459970 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42049860 |
| 53 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.41941433 |
| 54 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.41909027 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41743476 |
| 56 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.41288017 |
| 57 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.41199079 |
| 58 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.40690754 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40478121 |
| 60 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40302451 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.38639371 |
| 62 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.38471945 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36335583 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36335583 |
| 65 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.35916644 |
| 66 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35449375 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33422026 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32681117 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.32418278 |
| 70 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31721196 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.31476475 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31268087 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.30928608 |
| 74 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.30665915 |
| 75 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30273814 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29241245 |
| 77 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.29225138 |
| 78 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28552902 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28482634 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27176140 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25353973 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24603758 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24210161 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.24036348 |
| 85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23725866 |
| 86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23574856 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23372931 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23107645 |
| 89 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22326678 |
| 90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.21935001 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21841124 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21582806 |
| 93 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20883856 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.20796308 |
| 95 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19367648 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18972456 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.18090087 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17588094 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.17561154 |
| 100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17418955 |
| 101 | MAF_26560356_Chip-Seq_TH1_Human | 1.17221749 |
| 102 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15022678 |
| 103 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14791632 |
| 104 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.14563605 |
| 105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14489312 |
| 106 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14041874 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12794816 |
| 108 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.12767933 |
| 109 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12712125 |
| 110 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.10377204 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09691279 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09552991 |
| 113 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08864956 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08802802 |
| 115 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08002397 |
| 116 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 1.07218988 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06971015 |
| 118 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06578935 |
| 119 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06514176 |
| 120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06251254 |
| 121 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06149212 |
| 122 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.04914238 |
| 123 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04812576 |
| 124 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03843003 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 1.03582670 |
| 126 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.03537262 |
| 127 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03284160 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99950453 |
| 129 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98133543 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97642350 |
| 131 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97547595 |
| 132 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97487398 |
| 133 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.96734368 |
| 134 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96045791 |
| 135 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95780162 |
| 136 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95386904 |
| 137 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93948111 |
| 138 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93696268 |
| 139 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93418219 |
| 140 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92507252 |
| 141 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92432671 |
| 142 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92145545 |
| 143 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.91655990 |
| 144 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91303263 |
| 145 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91069989 |
| 146 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90975087 |
| 147 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90971100 |
| 148 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90851107 |
| 149 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.90847008 |
| 150 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.90102225 |
| 151 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89957881 |
| 152 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89780979 |
| 153 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.89554903 |
| 154 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89372371 |
| 155 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88818830 |
| 156 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88223232 |
| 157 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88052516 |
| 158 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87976304 |
| 159 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87586185 |
| 160 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87017543 |
| 161 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.86917252 |
| 162 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.86468036 |
| 163 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86371370 |
| 164 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86356173 |
| 165 | * MYB_26560356_Chip-Seq_TH2_Human | 0.86161808 |
| 166 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85928032 |
| 167 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85884118 |
| 168 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85583974 |
| 169 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85423309 |
| 170 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85393711 |
| 171 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85271066 |
| 172 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84002147 |
| 173 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83507245 |
| 174 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83225720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.99998269 |
| 2 | MP0000920_abnormal_myelination | 3.80300573 |
| 3 | MP0003303_peritoneal_inflammation | 3.39106552 |
| 4 | MP0006082_CNS_inflammation | 3.32563095 |
| 5 | MP0003690_abnormal_glial_cell | 2.81637441 |
| 6 | MP0003172_abnormal_lysosome_physiology | 2.78917136 |
| 7 | MP0000383_abnormal_hair_follicle | 2.71652772 |
| 8 | MP0004381_abnormal_hair_follicle | 2.65509095 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.58008211 |
| 10 | MP0000604_amyloidosis | 2.56072408 |
| 11 | MP0003436_decreased_susceptibility_to | 2.52038431 |
| 12 | MP0002419_abnormal_innate_immunity | 2.33113701 |
| 13 | MP0004510_myositis | 2.32182174 |
| 14 | MP0005410_abnormal_fertilization | 2.25450169 |
| 15 | MP0002796_impaired_skin_barrier | 2.25212399 |
| 16 | MP0005174_abnormal_tail_pigmentation | 2.19170324 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.18825659 |
| 18 | MP0005409_darkened_coat_color | 2.12146654 |
| 19 | MP0001835_abnormal_antigen_presentation | 2.11417254 |
| 20 | MP0003329_amyloid_beta_deposits | 2.10018838 |
| 21 | MP0005501_abnormal_skin_physiology | 2.07574605 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.03511045 |
| 23 | MP0005670_abnormal_white_adipose | 2.01763578 |
| 24 | MP0002089_abnormal_postnatal_growth/wei | 2.00052230 |
| 25 | MP0009840_abnormal_foam_cell | 1.96649597 |
| 26 | MP0001958_emphysema | 1.91973232 |
| 27 | MP0000015_abnormal_ear_pigmentation | 1.90526170 |
| 28 | MP0002098_abnormal_vibrissa_morphology | 1.89770689 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.89708410 |
| 30 | MP0003724_increased_susceptibility_to | 1.87339808 |
| 31 | MP0005025_abnormal_response_to | 1.87044489 |
| 32 | MP0001790_abnormal_immune_system | 1.86532526 |
| 33 | MP0005387_immune_system_phenotype | 1.86532526 |
| 34 | MP0004043_abnormal_pH_regulation | 1.82597979 |
| 35 | MP0002254_reproductive_system_inflammat | 1.81167145 |
| 36 | MP0004233_abnormal_muscle_weight | 1.79957495 |
| 37 | MP0000538_abnormal_urinary_bladder | 1.78504760 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.77625697 |
| 39 | MP0005171_absent_coat_pigmentation | 1.77393857 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.75418310 |
| 41 | MP0003634_abnormal_glial_cell | 1.74008095 |
| 42 | MP0009785_altered_susceptibility_to | 1.72654404 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.72362265 |
| 44 | MP0005365_abnormal_bile_salt | 1.71607697 |
| 45 | MP0006054_spinal_hemorrhage | 1.71329712 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.71139399 |
| 47 | MP0010771_integument_phenotype | 1.69685202 |
| 48 | MP0003448_altered_tumor_morphology | 1.69335664 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.67797582 |
| 50 | MP0003075_altered_response_to | 1.66341708 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.66304709 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.66194897 |
| 53 | MP0000427_abnormal_hair_cycle | 1.64135443 |
| 54 | MP0004858_abnormal_nervous_system | 1.62421697 |
| 55 | MP0005451_abnormal_body_composition | 1.58718488 |
| 56 | MP0001216_abnormal_epidermal_layer | 1.58373948 |
| 57 | MP0005023_abnormal_wound_healing | 1.57795996 |
| 58 | MP0001851_eye_inflammation | 1.56187388 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.54952367 |
| 60 | MP0002723_abnormal_immune_serum | 1.54134717 |
| 61 | MP0000467_abnormal_esophagus_morphology | 1.54110573 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.51961401 |
| 63 | MP0000579_abnormal_nail_morphology | 1.50876778 |
| 64 | MP0008872_abnormal_physiological_respon | 1.50438383 |
| 65 | MP0003718_maternal_effect | 1.50117848 |
| 66 | MP0005310_abnormal_salivary_gland | 1.49750347 |
| 67 | MP0002736_abnormal_nociception_after | 1.47344924 |
| 68 | MP0005595_abnormal_vascular_smooth | 1.45641202 |
| 69 | MP0000343_altered_response_to | 1.45323185 |
| 70 | MP0003011_delayed_dark_adaptation | 1.43348938 |
| 71 | MP0000685_abnormal_immune_system | 1.43140421 |
| 72 | MP0003195_calcinosis | 1.41288679 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.41038776 |
| 74 | MP0002136_abnormal_kidney_physiology | 1.38777283 |
| 75 | MP0004742_abnormal_vestibular_system | 1.36110002 |
| 76 | MP0008260_abnormal_autophagy | 1.35776195 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.35211328 |
| 78 | MP0001819_abnormal_immune_cell | 1.34921064 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.34717385 |
| 80 | MP0000371_diluted_coat_color | 1.34458578 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.34315788 |
| 82 | MP0001800_abnormal_humoral_immune | 1.33176250 |
| 83 | MP0004947_skin_inflammation | 1.32350721 |
| 84 | MP0003186_abnormal_redox_activity | 1.27864392 |
| 85 | MP0000747_muscle_weakness | 1.25529338 |
| 86 | MP0000377_abnormal_hair_follicle | 1.24725345 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 1.22962777 |
| 88 | MP0002933_joint_inflammation | 1.21891138 |
| 89 | MP0005166_decreased_susceptibility_to | 1.21756945 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.21207963 |
| 91 | MP0000003_abnormal_adipose_tissue | 1.19228915 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 1.19201798 |
| 93 | MP0005671_abnormal_response_to | 1.14817105 |
| 94 | MP0008469_abnormal_protein_level | 1.14286305 |
| 95 | MP0000470_abnormal_stomach_morphology | 1.14243277 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 1.13160265 |
| 97 | MP0002060_abnormal_skin_morphology | 1.12933342 |
| 98 | MP0002405_respiratory_system_inflammati | 1.12886516 |
| 99 | MP0010386_abnormal_urinary_bladder | 1.12751820 |
| 100 | MP0003638_abnormal_response/metabolism_ | 1.12527087 |
| 101 | MP0000367_abnormal_coat/_hair | 1.11239201 |
| 102 | MP0005332_abnormal_amino_acid | 1.09782784 |
| 103 | MP0005257_abnormal_intraocular_pressure | 1.08997846 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 1.08594113 |
| 105 | MP0009931_abnormal_skin_appearance | 1.07755446 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 1.04487852 |
| 107 | MP0001756_abnormal_urination | 1.04177410 |
| 108 | MP0010368_abnormal_lymphatic_system | 1.04169820 |
| 109 | MP0010030_abnormal_orbit_morphology | 1.03871307 |
| 110 | MP0005076_abnormal_cell_differentiation | 1.03445029 |
| 111 | MP0000750_abnormal_muscle_regeneration | 1.02786610 |
| 112 | MP0005164_abnormal_response_to | 1.01971291 |
| 113 | MP0001765_abnormal_ion_homeostasis | 1.01906211 |
| 114 | MP0000647_abnormal_sebaceous_gland | 1.01458946 |
| 115 | MP0005165_increased_susceptibility_to | 1.01121779 |
| 116 | MP0003806_abnormal_nucleotide_metabolis | 1.01109376 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 1.00174263 |
| 118 | MP0000358_abnormal_cell_content/ | 0.99228786 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.99204990 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.98276257 |
| 121 | MP0001919_abnormal_reproductive_system | 0.97977458 |
| 122 | MP0005389_reproductive_system_phenotype | 0.97417170 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.97076333 |
| 124 | MP0002160_abnormal_reproductive_system | 0.96313863 |
| 125 | MP0001873_stomach_inflammation | 0.95925894 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.93847675 |
| 127 | MP0003633_abnormal_nervous_system | 0.93453143 |
| 128 | MP0005083_abnormal_biliary_tract | 0.92335890 |
| 129 | MP0004272_abnormal_basement_membrane | 0.90783695 |
| 130 | MP0005408_hypopigmentation | 0.90780657 |
| 131 | MP0000372_irregular_coat_pigmentation | 0.89558421 |
| 132 | MP0000733_abnormal_muscle_development | 0.89028511 |
| 133 | MP0009333_abnormal_splenocyte_physiolog | 0.88553770 |
| 134 | MP0002295_abnormal_pulmonary_circulatio | 0.85949246 |
| 135 | MP0004133_heterotaxia | 0.85326304 |
| 136 | MP0009764_decreased_sensitivity_to | 0.84943016 |
| 137 | MP0003941_abnormal_skin_development | 0.83363586 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82626909 |
| 139 | MP0001191_abnormal_skin_condition | 0.81921937 |
| 140 | MP0000716_abnormal_immune_system | 0.81913648 |
| 141 | MP0000767_abnormal_smooth_muscle | 0.81019788 |
| 142 | MP0004885_abnormal_endolymph | 0.80930636 |
| 143 | MP0010678_abnormal_skin_adnexa | 0.79439164 |
| 144 | MP0003136_yellow_coat_color | 0.79268764 |
| 145 | MP0005636_abnormal_mineral_homeostasis | 0.78704795 |
| 146 | MP0002075_abnormal_coat/hair_pigmentati | 0.78641072 |
| 147 | MP0004019_abnormal_vitamin_homeostasis | 0.78007432 |
| 148 | MP0004264_abnormal_extraembryonic_tissu | 0.77891762 |
| 149 | MP0010155_abnormal_intestine_physiology | 0.77016339 |
| 150 | MP0005623_abnormal_meninges_morphology | 0.76857896 |
| 151 | MP0002229_neurodegeneration | 0.75274184 |
| 152 | MP0003631_nervous_system_phenotype | 0.74414260 |
| 153 | MP0003091_abnormal_cell_migration | 0.73806526 |
| 154 | MP0008004_abnormal_stomach_pH | 0.73120518 |
| 155 | MP0003632_abnormal_nervous_system | 0.72649004 |
| 156 | MP0001186_pigmentation_phenotype | 0.72214039 |
| 157 | MP0001663_abnormal_digestive_system | 0.71772765 |
| 158 | MP0005075_abnormal_melanosome_morpholog | 0.71461236 |
| 159 | MP0005647_abnormal_sex_gland | 0.70890951 |
| 160 | MP0003795_abnormal_bone_structure | 0.70885446 |
| 161 | MP0010329_abnormal_lipoprotein_level | 0.69926042 |
| 162 | MP0002332_abnormal_exercise_endurance | 0.69923206 |
| 163 | MP0002653_abnormal_ependyma_morphology | 0.69485918 |
| 164 | MP0000249_abnormal_blood_vessel | 0.69092851 |
| 165 | MP0009278_abnormal_bone_marrow | 0.68590917 |
| 166 | MP0003828_pulmonary_edema | 0.68540192 |
| 167 | MP0005666_abnormal_adipose_tissue | 0.67761465 |
| 168 | MP0005390_skeleton_phenotype | 0.67405908 |
| 169 | MP0002133_abnormal_respiratory_system | 0.67367916 |
| 170 | MP0005388_respiratory_system_phenotype | 0.67367916 |
| 171 | MP0002118_abnormal_lipid_homeostasis | 0.65933177 |
| 172 | MP0000858_altered_metastatic_potential | 0.64977502 |
| 173 | MP0001324_abnormal_eye_pigmentation | 0.64913995 |
| 174 | MP0005395_other_phenotype | 0.64706918 |
| 175 | MP0002090_abnormal_vision | 0.64458310 |
| 176 | MP0005377_hearing/vestibular/ear_phenot | 0.63051503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.05148287 |
| 2 | Axonal loss (HP:0003447) | 4.99844945 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.84059467 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.76264922 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.49429580 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.48392535 |
| 7 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.43487127 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.23272435 |
| 9 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.22784582 |
| 10 | Neurofibrillary tangles (HP:0002185) | 4.13122423 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.09590336 |
| 12 | Type II lissencephaly (HP:0007260) | 3.92350979 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.74967129 |
| 14 | Metabolic alkalosis (HP:0200114) | 3.69011826 |
| 15 | Hypomagnesemia (HP:0002917) | 3.61289600 |
| 16 | Peripheral hypomyelination (HP:0007182) | 3.59403967 |
| 17 | Hypokalemic alkalosis (HP:0001949) | 3.49230228 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.48747348 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.36687940 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.36687940 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.36687940 |
| 22 | Increased circulating renin level (HP:0000848) | 3.36212788 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 3.12980447 |
| 24 | Abnormality of magnesium homeostasis (HP:0004921) | 3.10498379 |
| 25 | Amelogenesis imperfecta (HP:0000705) | 3.09575549 |
| 26 | Cerebellar dysplasia (HP:0007033) | 3.06217319 |
| 27 | Loss of speech (HP:0002371) | 3.05606031 |
| 28 | Concave nail (HP:0001598) | 3.04922564 |
| 29 | Peripheral demyelination (HP:0011096) | 3.03562138 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 3.03161239 |
| 31 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.00965106 |
| 32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.00965106 |
| 33 | Menorrhagia (HP:0000132) | 2.99485868 |
| 34 | Disinhibition (HP:0000734) | 2.98171692 |
| 35 | Hypophosphatemic rickets (HP:0004912) | 2.94450355 |
| 36 | Abnormality of chloride homeostasis (HP:0011422) | 2.93342705 |
| 37 | Onion bulb formation (HP:0003383) | 2.92266955 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.86494638 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.86494638 |
| 40 | Congenital stationary night blindness (HP:0007642) | 2.86026946 |
| 41 | Congenital, generalized hypertrichosis (HP:0004540) | 2.83413837 |
| 42 | Petechiae (HP:0000967) | 2.80925648 |
| 43 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.77375044 |
| 44 | Stomatitis (HP:0010280) | 2.73570812 |
| 45 | Insidious onset (HP:0003587) | 2.72547163 |
| 46 | Termporal pattern (HP:0011008) | 2.72547163 |
| 47 | Attenuation of retinal blood vessels (HP:0007843) | 2.66043086 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65745708 |
| 49 | Obstructive lung disease (HP:0006536) | 2.65745708 |
| 50 | Tetany (HP:0001281) | 2.62947028 |
| 51 | Recurrent skin infections (HP:0001581) | 2.62680075 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60492132 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60492132 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60492132 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.58323232 |
| 56 | Hepatosplenomegaly (HP:0001433) | 2.57924753 |
| 57 | Septate vagina (HP:0001153) | 2.53911393 |
| 58 | Disproportionate short-trunk short stature (HP:0003521) | 2.51195528 |
| 59 | Renal Fanconi syndrome (HP:0001994) | 2.47160085 |
| 60 | Muscle fiber splitting (HP:0003555) | 2.47000772 |
| 61 | Abnormality of alanine metabolism (HP:0010916) | 2.46471081 |
| 62 | Hyperalaninemia (HP:0003348) | 2.46471081 |
| 63 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.46471081 |
| 64 | Polyuria (HP:0000103) | 2.44111421 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.43130297 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.43130134 |
| 67 | Ulnar claw (HP:0001178) | 2.41218128 |
| 68 | Increased corneal curvature (HP:0100692) | 2.39510164 |
| 69 | Keratoconus (HP:0000563) | 2.39510164 |
| 70 | Severe muscular hypotonia (HP:0006829) | 2.38870352 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.38150608 |
| 72 | Poikiloderma (HP:0001029) | 2.32771219 |
| 73 | Hyperactive renin-angiotensin system (HP:0000841) | 2.32559131 |
| 74 | Testicular atrophy (HP:0000029) | 2.31403611 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.29524829 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 2.28741007 |
| 77 | Abnormal urine output (HP:0012590) | 2.26149287 |
| 78 | Prolonged neonatal jaundice (HP:0006579) | 2.23645893 |
| 79 | Gingivitis (HP:0000230) | 2.21870444 |
| 80 | Sparse eyelashes (HP:0000653) | 2.21351825 |
| 81 | Parakeratosis (HP:0001036) | 2.20651742 |
| 82 | Increased CSF protein (HP:0002922) | 2.18663321 |
| 83 | Abnormality of renal excretion (HP:0011036) | 2.17624522 |
| 84 | J-shaped sella turcica (HP:0002680) | 2.17200124 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.14146379 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.14146379 |
| 87 | Stridor (HP:0010307) | 2.13910033 |
| 88 | Renal salt wasting (HP:0000127) | 2.13884444 |
| 89 | Bulbous nose (HP:0000414) | 2.13841313 |
| 90 | Abnormality of the corticospinal tract (HP:0002492) | 2.13440932 |
| 91 | Cellulitis (HP:0100658) | 2.11076314 |
| 92 | Abnormality of dental color (HP:0011073) | 2.10688311 |
| 93 | Vascular calcification (HP:0004934) | 2.09208372 |
| 94 | Type I transferrin isoform profile (HP:0003642) | 2.09105806 |
| 95 | Neuronal loss in central nervous system (HP:0002529) | 2.06959635 |
| 96 | Hyperlipoproteinemia (HP:0010980) | 2.03478514 |
| 97 | Anterior segment dysgenesis (HP:0007700) | 2.02201201 |
| 98 | Foot dorsiflexor weakness (HP:0009027) | 2.01963738 |
| 99 | Opisthotonus (HP:0002179) | 2.01191667 |
| 100 | Alopecia of scalp (HP:0002293) | 2.00774106 |
| 101 | Lissencephaly (HP:0001339) | 2.00761446 |
| 102 | Increased mean platelet volume (HP:0011877) | 2.00312978 |
| 103 | Polydipsia (HP:0001959) | 1.99281371 |
| 104 | Abnormal drinking behavior (HP:0030082) | 1.99281371 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98540910 |
| 106 | Pendular nystagmus (HP:0012043) | 1.96757506 |
| 107 | Increased serum ferritin (HP:0003281) | 1.95403701 |
| 108 | Abnormality of the nasal septum (HP:0000419) | 1.95203502 |
| 109 | Chorioretinal atrophy (HP:0000533) | 1.94613155 |
| 110 | Slow saccadic eye movements (HP:0000514) | 1.93572906 |
| 111 | Entropion (HP:0000621) | 1.93378466 |
| 112 | Juvenile onset (HP:0003621) | 1.92835743 |
| 113 | Congenital sensorineural hearing impairment (HP:0008527) | 1.92825504 |
| 114 | Akinesia (HP:0002304) | 1.92187904 |
| 115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91863711 |
| 116 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91728453 |
| 117 | Microretrognathia (HP:0000308) | 1.90470738 |
| 118 | Hyperventilation (HP:0002883) | 1.90138338 |
| 119 | Clumsiness (HP:0002312) | 1.89687047 |
| 120 | Apathy (HP:0000741) | 1.88546585 |
| 121 | Decreased central vision (HP:0007663) | 1.88482265 |
| 122 | Cardiovascular calcification (HP:0011915) | 1.88449303 |
| 123 | Aplasia of the musculature (HP:0100854) | 1.88292671 |
| 124 | Pathologic fracture (HP:0002756) | 1.87725943 |
| 125 | Purpura (HP:0000979) | 1.86600439 |
| 126 | Severe visual impairment (HP:0001141) | 1.86343936 |
| 127 | Spastic tetraparesis (HP:0001285) | 1.85828888 |
| 128 | Fatigable weakness (HP:0003473) | 1.85539094 |
| 129 | Abnormality of the neuromuscular junction (HP:0003398) | 1.85539094 |
| 130 | Glomerulonephritis (HP:0000099) | 1.85524353 |
| 131 | Hypoplasia of the iris (HP:0007676) | 1.85108519 |
| 132 | Abnormality of proline metabolism (HP:0010907) | 1.84756928 |
| 133 | Hydroxyprolinuria (HP:0003080) | 1.84756928 |
| 134 | Urticaria (HP:0001025) | 1.84116895 |
| 135 | Popliteal pterygium (HP:0009756) | 1.83276518 |
| 136 | Buphthalmos (HP:0000557) | 1.82661334 |
| 137 | Tongue fasciculations (HP:0001308) | 1.82638420 |
| 138 | Sensory axonal neuropathy (HP:0003390) | 1.81505411 |
| 139 | Diminished motivation (HP:0000745) | 1.81028104 |
| 140 | Thick nail (HP:0001805) | 1.79251941 |
| 141 | Hyperaldosteronism (HP:0000859) | 1.79061102 |
| 142 | Cerebral hemorrhage (HP:0001342) | 1.78467522 |
| 143 | Fragile nails (HP:0001808) | 1.77777512 |
| 144 | Amyloidosis (HP:0011034) | 1.77582780 |
| 145 | Abnormality of the lumbar spine (HP:0100712) | 1.74114654 |
| 146 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73941778 |
| 147 | Retinal dysplasia (HP:0007973) | 1.73916163 |
| 148 | Polymicrogyria (HP:0002126) | 1.73741252 |
| 149 | Squamous cell carcinoma (HP:0002860) | 1.72616804 |
| 150 | Abnormality of the foot musculature (HP:0001436) | 1.72539691 |
| 151 | Xanthomatosis (HP:0000991) | 1.72075308 |
| 152 | Lip pit (HP:0100267) | 1.71956580 |
| 153 | Hypoplasia of the odontoid process (HP:0003311) | 1.71284240 |
| 154 | Hepatic necrosis (HP:0002605) | 1.71172593 |
| 155 | Abnormal protein glycosylation (HP:0012346) | 1.70886996 |
| 156 | Abnormal glycosylation (HP:0012345) | 1.70886996 |
| 157 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.70886996 |
| 158 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.70886996 |
| 159 | Abnormality of DNA repair (HP:0003254) | 1.69287517 |
| 160 | Abnormal auditory evoked potentials (HP:0006958) | 1.69226686 |
| 161 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.68921514 |
| 162 | Esophageal varix (HP:0002040) | 1.68015083 |
| 163 | Long toe (HP:0010511) | 1.67390588 |
| 164 | Paralysis (HP:0003470) | 1.67345174 |
| 165 | Alkalosis (HP:0001948) | 1.67185358 |
| 166 | Gastrointestinal stroma tumor (HP:0100723) | 1.67102531 |
| 167 | Ureteral duplication (HP:0000073) | 1.66076779 |
| 168 | Recurrent fungal infections (HP:0002841) | 1.65900715 |
| 169 | Myocardial infarction (HP:0001658) | 1.65763218 |
| 170 | Absent thumb (HP:0009777) | 1.64508354 |
| 171 | Mesangial abnormality (HP:0001966) | 1.64276569 |
| 172 | Hammertoe (HP:0001765) | 1.64197508 |
| 173 | Abnormal platelet function (HP:0011869) | 1.63965024 |
| 174 | Impaired platelet aggregation (HP:0003540) | 1.63965024 |
| 175 | Ileus (HP:0002595) | 1.63603880 |
| 176 | Focal segmental glomerulosclerosis (HP:0000097) | 1.63522248 |
| 177 | Abnormality of iron homeostasis (HP:0011031) | 1.62670681 |
| 178 | Short femoral neck (HP:0100864) | 1.62146746 |
| 179 | Cutaneous melanoma (HP:0012056) | 1.61932611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.32705463 |
| 2 | FRK | 4.06346239 |
| 3 | EPHB1 | 3.88034315 |
| 4 | OXSR1 | 3.67964065 |
| 5 | WNK4 | 3.46080705 |
| 6 | MAPKAPK3 | 3.45217743 |
| 7 | EPHA2 | 3.23176029 |
| 8 | RIPK4 | 3.06141177 |
| 9 | PBK | 2.75669961 |
| 10 | BLK | 2.64558562 |
| 11 | ADRBK2 | 2.51518021 |
| 12 | BMPR1B | 2.46168732 |
| 13 | MUSK | 2.42146450 |
| 14 | ACVR1B | 2.39919459 |
| 15 | VRK2 | 2.35733718 |
| 16 | TBK1 | 2.19766645 |
| 17 | KSR2 | 1.93885755 |
| 18 | MST4 | 1.92135467 |
| 19 | SIK1 | 1.87369643 |
| 20 | MET | 1.86315856 |
| 21 | MST1R | 1.79471910 |
| 22 | BMX | 1.77929175 |
| 23 | INSRR | 1.77005978 |
| 24 | LMTK2 | 1.76516181 |
| 25 | TLK1 | 1.74162392 |
| 26 | MAP3K14 | 1.73020819 |
| 27 | WNK1 | 1.71961770 |
| 28 | MAP4K1 | 1.67591430 |
| 29 | TESK2 | 1.63787846 |
| 30 | NUAK1 | 1.61818646 |
| 31 | GRK1 | 1.59882897 |
| 32 | FGR | 1.58698835 |
| 33 | TIE1 | 1.56200935 |
| 34 | ADRBK1 | 1.52879005 |
| 35 | TGFBR1 | 1.51112055 |
| 36 | WNK3 | 1.40843691 |
| 37 | ERN1 | 1.38609131 |
| 38 | MAP3K13 | 1.38366988 |
| 39 | EIF2AK1 | 1.36307069 |
| 40 | ILK | 1.33033311 |
| 41 | SIK3 | 1.32535360 |
| 42 | LIMK1 | 1.30637036 |
| 43 | PKN1 | 1.28075518 |
| 44 | EPHB2 | 1.27788380 |
| 45 | LRRK2 | 1.24102987 |
| 46 | ZAK | 1.23654422 |
| 47 | MAP2K1 | 1.22844609 |
| 48 | NME2 | 1.21451476 |
| 49 | KIT | 1.21061038 |
| 50 | ABL2 | 1.18665410 |
| 51 | TRIB3 | 1.18248405 |
| 52 | CSK | 1.18217636 |
| 53 | TRIM28 | 1.17457963 |
| 54 | IKBKE | 1.16875130 |
| 55 | FER | 1.16702329 |
| 56 | RPS6KB2 | 1.16560859 |
| 57 | NTRK1 | 1.14076964 |
| 58 | TYK2 | 1.13298091 |
| 59 | MELK | 1.12527487 |
| 60 | FLT3 | 1.10051975 |
| 61 | PDPK1 | 1.09768804 |
| 62 | STK10 | 1.08802751 |
| 63 | MAPKAPK5 | 1.07878201 |
| 64 | MAP3K3 | 1.04761535 |
| 65 | CHUK | 1.04076808 |
| 66 | TAOK3 | 1.03268396 |
| 67 | MAP2K2 | 1.00895578 |
| 68 | PRKD2 | 1.00385223 |
| 69 | IKBKB | 0.99992069 |
| 70 | PRKCI | 0.99492262 |
| 71 | IRAK4 | 0.95984288 |
| 72 | MAP3K2 | 0.92667456 |
| 73 | PIK3CA | 0.92352416 |
| 74 | PAK6 | 0.91086872 |
| 75 | CDK8 | 0.90544524 |
| 76 | PTK2B | 0.87757786 |
| 77 | FES | 0.84849301 |
| 78 | CAMK1D | 0.84123895 |
| 79 | LCK | 0.83739631 |
| 80 | HCK | 0.82621211 |
| 81 | CAMK1G | 0.81981528 |
| 82 | JAK1 | 0.81828613 |
| 83 | CLK1 | 0.80577409 |
| 84 | ARAF | 0.79736178 |
| 85 | MOS | 0.79569794 |
| 86 | PDGFRB | 0.78108070 |
| 87 | ITK | 0.77677949 |
| 88 | MARK3 | 0.76292714 |
| 89 | PDK1 | 0.75449552 |
| 90 | JAK2 | 0.75201731 |
| 91 | ROCK2 | 0.75169446 |
| 92 | CSF1R | 0.74346174 |
| 93 | GRK5 | 0.73828910 |
| 94 | STK38 | 0.73616797 |
| 95 | SMG1 | 0.72916879 |
| 96 | TGFBR2 | 0.72871650 |
| 97 | NEK9 | 0.72633206 |
| 98 | MYLK | 0.71986620 |
| 99 | GSK3A | 0.71426555 |
| 100 | DAPK2 | 0.70477809 |
| 101 | TTN | 0.70378234 |
| 102 | PRKD1 | 0.69343040 |
| 103 | IRAK3 | 0.67951064 |
| 104 | PIM2 | 0.67902926 |
| 105 | MAP3K1 | 0.67642354 |
| 106 | ABL1 | 0.67088059 |
| 107 | TRPM7 | 0.66483436 |
| 108 | MAP4K2 | 0.66371996 |
| 109 | STK3 | 0.66101888 |
| 110 | TESK1 | 0.65668952 |
| 111 | ZAP70 | 0.64862798 |
| 112 | RET | 0.64686483 |
| 113 | SYK | 0.62494784 |
| 114 | DAPK3 | 0.61343694 |
| 115 | PRKG2 | 0.60215377 |
| 116 | ERBB4 | 0.59639762 |
| 117 | GRK6 | 0.59594965 |
| 118 | PRKCE | 0.59537579 |
| 119 | EGFR | 0.59201614 |
| 120 | FYN | 0.58253931 |
| 121 | TAF1 | 0.58163350 |
| 122 | PRKCQ | 0.58121159 |
| 123 | PAK4 | 0.57448014 |
| 124 | DDR2 | 0.57229425 |
| 125 | NME1 | 0.56795665 |
| 126 | PRKCH | 0.56296935 |
| 127 | PTK6 | 0.54098754 |
| 128 | RPS6KA2 | 0.53727868 |
| 129 | ICK | 0.52992775 |
| 130 | HIPK2 | 0.52766451 |
| 131 | MAP3K11 | 0.52337450 |
| 132 | TAOK2 | 0.52022873 |
| 133 | LYN | 0.51813610 |
| 134 | GRK7 | 0.51721462 |
| 135 | PRKD3 | 0.50571816 |
| 136 | CAMK2D | 0.48573395 |
| 137 | MATK | 0.47908195 |
| 138 | DAPK1 | 0.47761269 |
| 139 | CSNK1G3 | 0.47723352 |
| 140 | PRKCD | 0.46202507 |
| 141 | CSNK1A1L | 0.45972116 |
| 142 | SGK494 | 0.45502365 |
| 143 | SGK223 | 0.45502365 |
| 144 | MAPK11 | 0.45307951 |
| 145 | LATS2 | 0.45081307 |
| 146 | PTK2 | 0.44903911 |
| 147 | MTOR | 0.44277367 |
| 148 | TYRO3 | 0.43938980 |
| 149 | BTK | 0.43156563 |
| 150 | SRC | 0.41834132 |
| 151 | PKN2 | 0.40802659 |
| 152 | CDC42BPA | 0.40545493 |
| 153 | PDK2 | 0.40103132 |
| 154 | CDK9 | 0.40075715 |
| 155 | SCYL2 | 0.39985264 |
| 156 | INSR | 0.39266853 |
| 157 | DMPK | 0.38603116 |
| 158 | JAK3 | 0.38541389 |
| 159 | BCR | 0.38231531 |
| 160 | TAOK1 | 0.36891193 |
| 161 | STK38L | 0.34904959 |
| 162 | CAMK2G | 0.33528188 |
| 163 | PRKAA2 | 0.32075604 |
| 164 | MAPKAPK2 | 0.31590941 |
| 165 | PHKG2 | 0.30609102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.74435904 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.22673623 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.74049254 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.61702190 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.54085243 |
| 6 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.53574090 |
| 7 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.38473009 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.25921775 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.12904567 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.12237309 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.10520328 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02836632 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96843078 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.96132377 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92096763 |
| 16 | Bladder cancer_Homo sapiens_hsa05219 | 1.87859551 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85485759 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.84708290 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80603732 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.74703876 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74124985 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.66074332 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63081000 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.61596976 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59247668 |
| 26 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.58624245 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.56006347 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.55491063 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.50205669 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46457755 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.45569216 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44571140 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.44227817 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41578338 |
| 35 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.39831151 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.31558247 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31356393 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.30846419 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.29556594 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27322835 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26566876 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.25876482 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25645435 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15837844 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15318420 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15309939 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13980621 |
| 48 | Melanoma_Homo sapiens_hsa05218 | 1.12130307 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10028388 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08600536 |
| 51 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.08149261 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08108562 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07173173 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 1.06765972 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05702485 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02988021 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 1.02201916 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99108000 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.98635061 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96615239 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96300449 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95828374 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95170405 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.94683995 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94092514 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91867882 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90752411 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89849198 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89711395 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.89502231 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87716678 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87606653 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87141215 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86874113 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86389675 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85038223 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81412606 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81155413 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80684353 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78423385 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77945267 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.77860453 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.77512985 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77060028 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76790625 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76392660 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76226676 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.76053385 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75623194 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73758074 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72207871 |
| 92 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.71983755 |
| 93 | Proteasome_Homo sapiens_hsa03050 | 0.70479623 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69869463 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69839586 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 0.67838388 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67273895 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66621684 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65611738 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64397610 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64245614 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.62655494 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62405449 |
| 104 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.62360107 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61859606 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61436821 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.61292383 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60469935 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60465070 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60367065 |
| 111 | Homologous recombination_Homo sapiens_hsa03440 | 0.59659651 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58663118 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58289432 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56362966 |
| 115 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56356796 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55608302 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.55518219 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.55511756 |
| 119 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54625191 |
| 120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51416980 |
| 121 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50557289 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50510088 |
| 123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50349654 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50200186 |
| 125 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49992770 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.49184754 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48973581 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48930504 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47987754 |
| 130 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47675769 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47201359 |
| 132 | Focal adhesion_Homo sapiens_hsa04510 | 0.47183475 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46406037 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.46157573 |
| 135 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45729275 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45633657 |
| 137 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45066688 |
| 138 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44117009 |
| 139 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43200258 |
| 140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43032359 |
| 141 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42472523 |
| 142 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41634694 |
| 143 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41448511 |
| 144 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40170721 |
| 145 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39715062 |
| 146 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39449934 |
| 147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39438800 |
| 148 | Purine metabolism_Homo sapiens_hsa00230 | 0.38194612 |
| 149 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37993987 |
| 150 | Influenza A_Homo sapiens_hsa05164 | 0.37584630 |
| 151 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37343920 |
| 152 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34761900 |
| 153 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33191103 |
| 154 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33142700 |
| 155 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32506323 |
| 156 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31710952 |
| 157 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31674381 |
| 158 | Tight junction_Homo sapiens_hsa04530 | 0.29114708 |
| 159 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25800442 |

